C. Tolosa-Vilella

发表

Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2017, Autoimmunity reviews.

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

N. Ortego-Centeno, V. Fonollosa-Plá, L. Dos Subirá, 2022, Scientific reports.

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

V. Fonollosa-Plá, M. Vilardell‐Tarrés, C. Tolosa-Vilella, 2011, Clinical Rheumatology.

Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study

N. Ortego-Centeno, G. Espinosa, V. Fonollosa-Plá, 2019, The Journal of Rheumatology.

Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2018, Clinical Rheumatology.

Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging.

C. Tolosa-Vilella, C. Simeón-Aznar, J. Ordi‐Ros, 1992, British journal of rheumatology.

Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group

R. Ríos-Fernandez, N. Ortego-Centeno, V. Fonollosa Plá, 2018, Rheumatology International.

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

J. Callejas-Rubio, N. Ortego-Centeno, V. Fonollosa-Plá, 2012, Seminars in arthritis and rheumatism.

Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.

J. C. Callejas Rubio, A. Guillén-del Castillo, V. Fonollosa-Plá, 2016, Seminars in arthritis and rheumatism.

Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2017, Seminars in arthritis and rheumatism.

Registry of the Spanish Network for Systemic Sclerosis

J. Callejas-Rubio, N. Ortego-Centeno, V. Fonollosa-Plá, 2015, Medicine.

The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).

N. Ortego-Centeno, V. Fonollosa-Plá, L. Trapiella-Martínez, 2020, Rheumatology.

[Prognostic implications of extra-hepatic clinical manifestations, autoimmunity and microscopic nail capillaroscopy in patients with primary biliary cirrhosis].

V. Fonollosa-Plá, C. Tolosa-Vilella, C. Simeón-Aznar, 2016 .

Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.

A. Guillén del Castillo, V. Fonollosa-Plá, M. Vilardell‐Tarrés, 2014, Clinical and experimental rheumatology.

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

N. Ortego-Centeno, V. Fonollosa-Plá, C. Tolosa-Vilella, 2022, Autoimmunity reviews.

Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis

N. Ortego-Centeno, A. Guillén del Castillo, G. Espinosa, 2021, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study

N. Ortego-Centeno, L. Sáez Cómet, J. J. Ríos Blanco, 2018, Clinical Rheumatology.

Clinical features of systemic sclerosis patients with anti-RNA polymerase III antibody in a single centre in Spain.

V. Fonollosa-Plá, A. Marín-Sánchez, C. Tolosa-Vilella, 2019, Clinical and experimental rheumatology.

Applying the ACR/EULAR Systemic Sclerosis Classification Criteria to the Spanish Scleroderma Registry Cohort

N. Ortego-Centeno, V. Fonollosa-Plá, L. Trapiella-Martínez, 2015, The Journal of Rheumatology.

Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report.

C. Tolosa-Vilella, M. Monteagudo-Jiménez, C. Capela, 2011, Clinical and experimental rheumatology.

Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

M. Vilardell‐Tarrés, C. Tolosa-Vilella, J. Ordi‐Ros, 1990, Annals of the rheumatic diseases.

Raynaud's phenomenon andpositive antinuclear antibodies ina malignancy

M. Vilardell‐Tarrés, C. Tolosa-Vilella, Albert Selva-O, 1990 .

Mesangioproliferative glomerulonephritis and antibodies to phospholipids in a patient with acute Q fever: case report.

C. Tolosa-Vilella, A. Rodríguez-Jornet, J. Font-Rocabanyera, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Olanzapine-induced agranulocytosis A case report and review of the literature

C. Tolosa-Vilella, B. Marí-alfonso, A. Ruiz-Ripoll, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis

V. Fonollosa-Plá, S. Alonso-Vila, C. Tolosa-Vilella, 2018, Arthritis Research & Therapy.

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study

V. Fonollosa-Plá, X. Muñoz, M. Vilardell‐Tarrés, 2008, The open respiratory medicine journal.

Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group

R. Ríos-Fernandez, N. Ortego-Centeno, J. Callejas, 2018, Rheumatology International.

Registry of the Spanish Network for Systemic Sclerosis

J. Callejas-Rubio, N. Ortego-Centeno, V. Fonollosa-Plá, 2015, Medicine.

Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2017, Autoimmunity reviews.